| 发明名称 |
USE OF ALDOSTERONE ANTAGONISTS TO INHIBIT MYOCARDIAL FIBROSIS |
| 摘要 |
This invention discloses a method of using an aldosterone antagonist such as spironolactone and epoxymexrenone, at a dosage which does not disrupt a patient's normal electrolyte and water-retention balance, to inhibit myocardial fibrosis, including left ventricular hypertrophy (LVH).
|
| 申请公布号 |
WO9515166(A1) |
申请公布日期 |
1995.06.08 |
| 申请号 |
WO1994US13291 |
申请日期 |
1994.12.01 |
| 申请人 |
CURATORS OF THE UNIVERSITY OF MISSOURI;WEBER, KARL, T. |
发明人 |
WEBER, KARL, T. |
| 分类号 |
A61K45/00;A61K31/00;A61K31/56;A61K31/585;A61P9/00;C07J1/00;C07J21/00;(IPC1-7):A61K31/585 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
